Amrutanjan Health Care Share Price

Overview
Recos
News
Analysis
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About

Amrutanjan Health Care Share Price

553.55-1.11 (-0.20%)

Live
As On: 16 Jun, 2026, 12:36 PM IST
As On: 16 Jun, 2026, 12:37 PM IST

Sector: Pharmaceuticals
Industry: Pharma - Indian

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Try ETMarkets GPTNEW

Open	554.65
High	561.70
Low	552.00
Prev Close	554.65
Volume	16,706
VWAP(₹)	556.58

Key Metrics

PE Ratio(x)	27.60
EPS - TTM(₹)	20.03
MCap(₹ Cr.)	1,599.48
MCap Rank	83
PB Ratio(x)	12.72
Div Yield(%)	0.89
Face Value(₹)	1.00
52W High(₹)	790.95
52W Low(₹)	486.00
MCap/Sales	3.85
Beta(1 Month)	1.41
BV/Share(₹)	43.59

Amrutanjan Health Care share price insights

Zero Debt Burden
Company has no debt since last 5 years. (Source: Standalone Financials)
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 12.69% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)
Amrutanjan Health Care Share Price Update
Amrutanjan Health Care Ltd. share price moved down by -0.20% from its previous close of Rs 554.65. Amrutanjan Health Care Ltd. stock last traded price is 553.55
Share Price Value
Today/Current/Last 553.55553.30
Previous Day 554.65553.70

Found Insights useful?

Amrutanjan Health Care Share Price Returns

1 Day	-0.2%
1 Month	-0.23%
3 Months	5.46%
1 Year	-20.79%
3 Years	-13.58%
5 Years	-20.61%

Amrutanjan Health Care Share Recommendations

Recent Recos

Target₹970
OrganizationHDFC Securities
BUY

Target₹970
OrganizationHDFC Securities
BUY

View all Stock Recommendations

News & Analysis

View all Amrutanjan Health Care Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	154.50	145.16	122.00	98.47	140.23
Total Income Growth (%)	6.43	18.99	23.89	-29.78	10.32
Total Expenses	133.44	118.75	102.73	87.13	119.33
Total Expenses Growth (%)	12.37	15.59	17.91	-26.99	18.07
EBIT	21.06	26.41	19.26	11.34	20.90
EBIT Growth (%)	-20.26	37.10	69.82	-45.72	-19.76
Profit after Tax (PAT)	16.19	19.45	13.96	8.31	15.18
PAT Growth (%)	-16.76	39.33	67.99	-45.24	-21.14
EBIT Margin (%)	13.63	18.20	15.79	11.52	14.90
Net Profit Margin (%)	10.48	13.40	11.44	8.44	10.82
Basic EPS (₹)	5.60	6.73	4.83	2.87	5.25

Annual	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Total Revenue	228.81	192.42	171.04	144.67	141.92
Total Revenue Growth (%)	18.91	12.50	18.23	1.94	-3.93
Total Expenses	198.26	159.74	146.73	125.29	126.44
Total Expenses Growth (%)	24.11	8.87	17.11	-0.91	-3.92
Profit after Tax (PAT)	21.14	20.58	15.07	12.44	10.12
PAT Growth (%)	2.76	36.50	21.13	23.00	5.00
Operating Profit Margin (%)	13.83	17.73	15.02	14.92	13.04
Net Profit Margin (%)	9.43	11.01	9.04	8.78	7.34
Basic EPS (₹)	14.47	14.08	10.31	8.51	6.92

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	520.13	469.50	437.58	394.18	421.22
Total Revenue Growth (%)	10.78	7.29	11.01	-6.42	22.39
Total Expenses	433.38	400.36	375.63	340.53	330.65
Total Expenses Growth (%)	8.25	6.58	10.31	2.99	26.08
Profit after Tax (PAT)	57.92	50.83	44.97	39.83	67.19
PAT Growth (%)	13.93	13.03	12.90	-40.71	9.80
Operating Profit Margin (%)	17.29	15.34	14.74	14.15	22.43
Net Profit Margin (%)	11.52	11.25	10.67	10.49	16.55
Basic EPS (₹)	20.03	17.58	15.50	13.65	23.00

All figures in Rs Cr, unless mentioned otherwise

Insights

Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 12.69% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)

Annual	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Total Assets	161.76	140.44	123.90	120.27	124.16
Total Assets Growth (%)	15.18	13.35	3.02	-3.13	-13.47
Total Liabilities	35.75	31.70	28.95	31.03	41.89
Total Liabilities Growth (%)	12.77	9.49	-6.70	-25.93	-10.92
Total Equity	126.01	108.74	94.95	89.24	82.27
Total Equity Growth (%)	15.88	14.52	6.40	8.47	-14.72
Current Ratio (x)	3.46	3.59	3.20	2.87	1.67
Total Debt to Equity (x)	0.02	0.02	0.03	0.09	0.18
Contingent Liabilities	0.00	29.36	24.65	22.24	16.44

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	508.89	421.39	366.87	362.09	349.87
Total Assets Growth (%)	20.76	14.86	1.32	3.49	27.56
Total Liabilities	138.66	94.77	78.38	71.32	84.74
Total Liabilities Growth (%)	46.31	20.91	9.90	-15.84	44.34
Total Equity	370.23	326.61	288.49	290.77	265.12
Total Equity Growth (%)	13.36	13.21	-0.78	9.67	22.99
Current Ratio (x)	2.31	3.44	4.23	4.12	3.55
Total Debt to Equity (x)	0.00	0.00	0.00	0.00	0.00
Contingent Liabilities	0.00	36.12	15.90	10.12	11.39

All figures in Rs Cr, unless mentioned otherwise

Insights

Zero Debt Burden
Company has no debt since last 5 years. (Source: Standalone Financials)

Annual	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Net Cash flow from Operating Activities	0.00	20.70	18.32	17.45	8.71
Net Cash used in Investing Activities	0.00	4.16	-4.89	16.49	5.22
Net Cash flow from Financing Activities	0.00	-13.10	-11.93	-13.92	-14.26
Net Cash Flow	0.00	11.76	1.49	20.02	-0.33
Closing Cash & Cash Equivalent	0.00	42.42	30.67	29.17	14.91
Closing Cash & Cash Equivalent Growth (%)	-100.00	38.33	5.12	95.71	-2.18
Total Debt/ CFO (x)	-	0.12	0.14	0.46	1.73

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	35.97	50.90	27.91	20.18	52.20
Net Cash used in Investing Activities	-21.23	-30.97	19.17	-2.48	-36.21
Net Cash flow from Financing Activities	-13.62	-13.49	-48.27	-14.99	-16.70
Net Cash Flow	1.12	6.44	-1.19	2.72	-0.72
Closing Cash & Cash Equivalent	11.27	10.16	3.71	4.90	2.19
Closing Cash & Cash Equivalent Growth (%)	11.00	173.58	-24.29	124.26	-24.75
Total Debt/ CFO (x)	0.00	0.00	0.00	0.00	0.00

All figures in Rs Cr, unless mentioned otherwise

Insights

Decrease in Cash from Investing
Company has used Rs 21.23 cr for investing activities which is an YoY decrease of 31.45%. (Source: Standalone Financials)

Annual	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Return on Equity (%)	16.77	18.92	15.87	13.94	12.29
Return on Capital Employed (%)	23.87	29.45	25.52	22.73	20.83
Return on Assets (%)	13.07	14.65	12.16	10.34	8.14
Interest Coverage Ratio (x)	78.72	75.81	35.20	11.97	7.24
Asset Turnover Ratio (x)	1.48	132.97	134.43	117.84	110.86
Price to Earnings (x)	40.82	29.67	46.51	14.75	16.78
Price to Book (x)	6.85	5.61	7.36	2.06	2.06
EV/EBITDA (x)	24.16	15.47	23.51	6.31	7.83
EBITDA Margin (%)	15.11	19.52	16.95	17.46	15.75

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	15.64	15.56	15.58	13.69	25.34
Return on Capital Employed (%)	22.71	20.59	20.91	17.96	33.42
Return on Assets (%)	11.38	12.06	12.25	11.00	19.20
Interest Coverage Ratio (x)	478.25	346.16	434.97	764.38	195.78
Asset Turnover Ratio (x)	1.08	1.15	1.16	1.07	1.30
Price to Earnings (x)	24.75	36.76	39.84	42.19	34.60
Price to Book (x)	3.86	5.71	6.20	5.78	8.75
EV/EBITDA (x)	14.99	23.47	25.85	27.32	23.54
EBITDA Margin (%)	18.55	16.79	16.18	15.52	23.37

Found Financials useful?

Technicals

Buy/Sell Signals
No Data Available
Price Analysis
No Data Available
Pivot Levels
R1 - Pivot
-
S1 -
R2 - S2 -
R3 - S3 -
Average True Range
5 Days 14 Days 28 Days
- - -

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Amrutanjan Health Care	27.60	12.69	16.77	23.87	13.07	9.58	13.83	9.43	14.47	3.46	0.02	0.00
Indoco Remedies	-22.84	2.33	-10.13	1.21	-3.66	3.39	1.01	-5.34	-10.70	1.13	1.10	5.39
Beta Drugs	50.46	8.55	16.94	17.98	8.36	20.01	18.11	10.77	40.92	3.10	0.60	3.96
NGL Fine Chem	37.89	5.53	14.61	17.15	8.82	21.81	13.54	9.60	77.90	1.84	0.33	2.50
Ind-Swift Labs	34.43	1.03	2.99	4.33	2.47	-17.67	9.58	6.44	4.95	3.83	0.01	-0.28
Add More

Annual Ratios (%)

Choose from Peers

Jagsonpal Pharm
Syncom Form
Lincoln Pharma
Bajaj Healthcare
Fermenta Biotech

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

Shareholding Pattern

Total Shareholdings
Category No. of Shares Percentage % Change QoQ
Promoters 1,34,48,190 46.52 % 0.00
Pledge 0 0.00 % 0.00
FII 6,28,598 2.17 % -0.10
DII 36,35,191 12.57 % -0.33
MF 20,29,448 7.02 % -0.53
Others 1,11,98,651 38.73 % 0.43
QoQ Change
Category Mar 2026 Dec 2025 Sep 2025 Jun 2025
Promoters 46.52 46.52 46.52 46.52
Pledge 0.00 0.00 0.00 0.00
FII 2.17 2.27 2.38 2.41
DII 12.57 12.91 12.80 12.61
Mutual Funds 7.02 7.55 7.55 7.55
Others 38.73 38.30 38.30 38.45

Mutual Funds Ownership

MF Ownership as on 31 May 2026

DSP Small Cap Direct-G
Equity: Small Cap
3
- 67.52
  Amount Invested (in Cr.)
- 0.37%
  % of AUM
- -11.22
  % Change (MoM basis)
ICICI Pru FMCG Direct-G
Equity: Thematic
- 32.90
  Amount Invested (in Cr.)
- 2.03595247%
  % of AUM
- 0.00
  % Change (MoM basis)

View all Mutual Fund Schemes

Amrutanjan Health Care Top Searches

Corporate Actions

Recent
General Meeting
-
May 19, 2026
General Meeting
-
May 18, 2026
Final
290%
May 08, 2026

Announced on	Meeting on
Apr 30, 2026	May 08, 2026
Audited Results & Final Dividend
Jan 28, 2026	Feb 03, 2026
Quarterly Results & Interim Dividend
Nov 04, 2025	Nov 10, 2025
Quarterly Results & Interim Dividend
Aug 06, 2025	Aug 12, 2025
Quarterly Results
May 08, 2025	May 15, 2025
Audited Results & Final Dividend

Dividends
Announced on Ex-Date Dividend%
Feb 03, 2026 Feb 06, 2026 100%
Nov 10, 2025 Nov 18, 2025 100%
May 15, 2025 Sep 16, 2025 260%
Feb 12, 2025 Feb 18, 2025 100%
May 08, 2026 - 290%

Announced on	Ex-Date
Sep 22, 2001	-
Bonus Ratio: 1 share(s) for every 1 shares held
Aug 11, 2001	Oct 29, 2001
Bonus Ratio: 1 share(s) for every 1 shares held
Aug 10, 2001	-
Bonus Ratio: 3 share(s) for every 4 shares held
Sep 30, 1993	Dec 21, 1992
Bonus Ratio: 1 share(s) for every 3 shares held
Sep 30, 1992	-
Bonus Ratio: 1 share(s) for every 3 shares held

Splits
Announced on Ex-Date
Feb 13, 2018 Apr 13, 2018
Split: Old FV2.0| New FV:1.0
Aug 06, 2012 Oct 25, 2012
Split: Old FV10.0| New FV:2.0
Rights
No Data Available
AGM/EGM Meetings
Announced on Meeting on
May 19, 2026 Jun 22, 2026
-
May 18, 2026 Jun 20, 2026
-
Aug 29, 2025 Sep 23, 2025
-
Aug 19, 2024 Sep 23, 2024
Rs.2.6000 per share(260%)Final Dividend & A.G.M.
Nov 28, 2023 Dec 29, 2023
-

About Amrutanjan Health Care

Amrutanjan Health Care Ltd., incorporated in the year 1936, is a Small Cap company (having a market cap of Rs 1,603.53 Crore) operating in Pharmaceuticals sector.

Amrutanjan Health Care Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services, Raw Materials and Scrap for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Standalone Total Income of Rs 154.50 Crore, up 6.43 % from last quarter Total Income of Rs 145.16 Crore and up 10.17 % from last year same quarter Total Income of Rs 140.23 Crore. Company has reported net profit after tax of Rs 16.19 Crore in latest quarter.

The company’s top management includes Mr.S Sambhu Prasad, Mr.G Raghavan, Ms.Ramaa Prabhakar Arikirevula, Ms.Meenalochani Raghunathan, Mr.Raja Venkataraman, Mr.S Muralidharan, Mr.V Nagaraj, Mr.N Swaminathan, Mr.S Jeyakanth, Mr.Gagan Preet Singh. Company has BSR & Co. LLP as its auditors. As on 31-03-2026, the company has a total of 2.89 Crore shares outstanding.

Amrutanjan Health Care Share Price Today is Rs. 553.55. On previous day, the Amrutanjan Health Care Share Price (NSE) closed at Rs. 557.7, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 46.52% of the stake in Amrutanjan Health Care shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Amrutanjan Health Care stocks was 2.17% as compared to 2.27% in Dec 2025 with decrease of 0.1%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 12.57% as compared to 12.91% in Dec 2025 with decrease of 0.34%. Out of the total DII holdings in Amrutanjan Health Care shares 7.02% was held by mutual funds. The rest including public held is 38.74%. Amrutanjan Health Care stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Amrutanjan Health Care Dividend: Ever since 1936, Amrutanjan Health Care dividends has been paid out around 60 times. As on 16 Jun, 2026, 12:36 PM IST, The overall dividend yield for Amrutanjan Health Care stands at 0.88%. The last dividend paid was on February 6, 2026 (Rs. 1.0). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 20.03.

Amrutanjan Health Care Bonus: The most recent bonus issue had been in year October 29, 2001 around 24 years ago at 1 : 1 ratio. The first bonus issue was announced in Sep 1983.

Stock Forecast:
After showing 154.5 Cr. of sales and 6.43% of quarterly net profit, there have been multiple ups and downs in the Amrutanjan Health Care stock prices in the past few weeks. For example, Amrutanjan Health Care stock price on 8th of June 2026 was around Rs. 556.95. Amrutanjan Health Care share price now stands at an average of Rs. 553.55. Judging by last week's performance, stock is in up trend.

Amrutanjan Health Care has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for Amrutanjan Health Care share.

Historical Prices and Performance:
Amrutanjan Health Care, incorporated in 1936 is a Small Cap company (with a market cap of Rs. 1603.53) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by Amrutanjan Health Care stock was 15.64%, 15.56%, 15.58%, 13.69% and 25.34% respectively.
The Amrutanjan Health Care share gave a 3 year return of -13.93% as compared to Nifty 50 which gave a return of 27.64%.
Amrutanjan Health Care announced 100.0% final dividend on February 6, 2026.

Key Metrics:
PE Ratio of Amrutanjan Health Care is 27.84
Prices/Sales Ratio of Amrutanjan Health Care is 3.85
Price/Book Ratio of Amrutanjan Health Care is 12.79

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Amrutanjan Health Care, major competitors and peers include Bliss GVS Pharma, SMS Pharma, Panacea Biotec and Solara Active Pharma. As of Dec 2025, the dividend yield of Amrutanjan Health Care stands at 0.88% while Bliss GVS Pharma, SMS Pharma, Panacea Biotec and Solara Active Pharma stand at 0.34%, 0.11%, 0.0% and 0.0% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 27.84 and 12.79 respectively.

Leadership of Amrutanjan Health Care :
Soumomoy Pal is Associate Vice President
J Ravichandran is Associate Vice President
Mani Bhagavatheeswaran is Chief Marketing Officer
N Swaminathan is Chief Financial Officer
S Jeyakanth is Chief Operating Officer
Gagan Preet Singh is GM (Legal) & Co. Secretary
S Sambhu Prasad is Chairman & Managing Director
G Raghavan is Non Executive Director
Ramaa Prabhakar Arikirevula is Non Executive Director
Meenalochani Raghunathan is Ind. Non-Executive Director
Raja Venkataraman is Ind. Non-Executive Director
S Muralidharan is Ind. Non-Executive Director
V Nagaraj is Ind. Non-Executive Director

Show More

Industry

Pharma - Indian

Key Indices Listed On

-

Address

No.103 (Old No.42-45),Chennai (Madras), Tamil Nadu - 600004

Contact

shares@amrutanjan.com

http://www.amrutanjan.com

Executive Leadership

SS

S Sambhu Prasad

Chairman & Managing Director

GR

G Raghavan

Non Executive Director

RP

Ramaa Prabhakar Arikirevula

Non Executive Director

MR

Meenalochani Raghunathan

Ind. Non-Executive Director

Show More

Auditors

BSR & Co. LLP

FAQs about Amrutanjan Health Care share

1. What is Amrutanjan Health Care share price and what are the returns for Amrutanjan Health Care share?
Amrutanjan Health Care share price is Rs 553.55 as on 16 Jun, 2026, 12:36 PM IST. Amrutanjan Health Care share price is down by 0.20% based on previous share price of Rs. 557.7.
2. What is the PE & PB ratio of Amrutanjan Health Care?
The PE ratio of Amrutanjan Health Care stands at 27.69, while the PB ratio is 4.33.
3. What are the returns for Amrutanjan Health Care share?
Return Performance of Amrutanjan Health Care Shares:
- 1 Week: Amrutanjan Health Care share price moved down by 1.34%
4. What is 52 week high/low of Amrutanjan Health Care share price?
52 Week high of Amrutanjan Health Care share is Rs 790.95 while 52 week low is Rs 486.00
5. What's the market capitalization of Amrutanjan Health Care?
Market Capitalization of Amrutanjan Health Care stock is Rs 1,599.48 Cr.

Top Gainers

As on 12:33 PM | 16 Jun 2026

Sonata Software

305.75

45.40 (17.44%)

1,021.95

115.91 (12.80%)

74.92

4.74 (6.74%)

PG Electroplast

524.45

31.66 (6.43%)

Netweb Technologies

4,850.70

238.40 (5.17%)

Top Losers

As on 12:33 PM | 16 Jun 2026

362.35

-24.90 (-6.43%)

359.25

-23.11 (-6.05%)

17,836.00

-820.00 (-4.40%)

974.60

-39.30 (-3.88%)

1,397.90

-54.10 (-3.73%)

Equity Quick Links

Top Gainers
Top Losers
Hourly gainers
Hourly losers
Sensex
Nifty
NSE
BSE

Midcap stocks
Smallcap stocks
Largecap stocks
Sensex
Nifty
NSE
BSE
MCX Live

More from Markets

IPO
Stock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.